Alpine Global Management’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-4,623
Closed -$274K 776
2021
Q3
$274K Buy
+4,623
New +$304K 0.06% 178
2020
Q3
Sell
-17,179
Closed -$1.01M 255
2020
Q2
$1.01M Buy
+17,179
New +$1.03M 0.18% 93
2017
Q2
Sell
-9,234
Closed -$502K 155
2017
Q1
$502K Buy
+9,234
New +$506K 0.13% 140
2015
Q3
Sell
-7,536
Closed -$501K 184
2015
Q2
$501K Sell
7,536
-12,548
-62% -$827K 0.08% 177
2015
Q1
$1.29M Sell
20,084
-16,682
-45% -$1.04M 0.42% 50
2014
Q4
$2.17M Buy
+36,766
New +$2.07M 0.39% 64

Other funds holding BMY

Alpine Global Management's BMY Position: Q4 2021 in Review

Alpine Global Management sold out of Bristol-Myers Squibb (BMY) in Q4 2021, closing a stake of 4,623 shares — an estimated $274K sold.

Alpine Global Management first reported a position in BMY in Q4 2014 and held it in 6 quarters. The position peaked at $2.17M in Q4 2014. 2,444 funds tracked by Wall St. Rank hold BMY as of Q4 2021.

  • Alpine Global Management reported no remaining Bristol-Myers Squibb position as of Q4 2021 after selling out during the quarter.
  • Alpine Global Management sold 4,623 Bristol-Myers Squibb shares in Q4 2021, an estimated $274K.
  • Alpine Global Management first reported a position in Bristol-Myers Squibb in Q4 2014 and held it in 6 quarters.
  • Alpine Global Management's Bristol-Myers Squibb position peaked at $2.17M in Q4 2014.
  • 2,444 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2021.

Based on Alpine Global Management's 13F filing for Q4 2021, filed 14 Feb 2022.